期刊文献+

盐酸法舒地尔治疗不稳定型心绞痛的临床疗效研究 被引量:2

Clinical effect research of hydrochloride fasudil in treatment of unstable angina pectoris
暂未订购
导出
摘要 目的:评价盐酸法舒地尔注射液治疗不稳定型心绞痛的临床疗效。方法:将86例不稳定型心绞痛患者随机分为对照组和治疗组,对照组43例,予以常规治疗,包括常规休息、吸氧、硝酸酯类、阿司匹林、氯吡格雷、低分子肝素及调脂药等常规治疗,心绞痛发作时舌下含服硝酸甘油片。治疗组43例,常规治疗外加盐酸法舒地尔注射液,静脉输注,2次/d,每次30mg。两组均治疗14d。观察评价两组的治疗前后48h内心绞痛发作情况和治疗效果。结果:心绞痛在治疗前后48h内发作情况,同组比较和两组比较,差异均有统计学意义(P<0.05);治疗组心绞痛症状改善总有效率为93.02%,明显优于对照组的58.14%。两者比较,差异有统计学意义(P<0.05)。结论:盐酸法舒地尔注射液治疗不稳定型心绞痛疗效确切。 Objective:To evaluate the clinical curative effect of hydrochloride fasudil in unstable angina pectoris.Methods:86 patients with unstable angina pectoris were randomly divided into control group and treatment group,the control group 43 cases were given routine treatment,included regular rest,oxygen,nitric acid ester,aspirin,clopidogrel,low molecular heparin and lipid conventional medicine treatment,angina tongue when including nitroglycerin piece.The treatment group 43 cases were given routine therapy plus hydrochloride fasudil,intravenous injection,two times a day,each time 30 mg.Both groups treatment for 14 days.Angina and therapeutic effect within 48 h before and after treatment were observed and evaluated.Results:Angina in 48 h before and after treatment within the same group,compared and attack two groups of comparisons were significant(P〈0.05);the total effective rate of angina symptoms improvment in the treatment group was 93.02%,which was significantly better than the 58.14% of control group,both comparative differences was significant(P〈0.05).Conclusion:The effect of hydrochloride fasudil in treatment of unstable angina symptoms is well.
作者 沈志方
出处 《中国当代医药》 2011年第28期44-45,共2页 China Modern Medicine
关键词 盐酸法舒地尔 不稳定型心绞痛 临床疗效 观察 Hydrochloride fasudil Unstable angina Clinical effect Observation
  • 相关文献

参考文献5

  • 1不稳定性心绞痛诊断和治疗建议[J].中华心血管病杂志,2000,28(6):409-412. 被引量:2697
  • 2SAENGER AK,JAFFE AS.The use of bjomarkem for the evuation and tretment of patients with acute coronflry syndromes[J].Med Clin Noah Am,2007,9 1 (4):657-681.
  • 3陈灏珠,戴自英,林果为,等.实用内科学[M].12版.北京:人民卫生出版社,2005.1333—1336.
  • 4Nohria A,Grunert ME,Rikitake Y,et al.Rhokinase inhibition improves endothelial function inhuman subject with coronary artery disease[J].Circ Res,2006,99(12):1426-1432.
  • 5甘斌.不稳定型心绞痛患者的药学监护模式的探索[J].中外医学研究,2010,8(28):174-176. 被引量:1

二级参考文献4

  • 1卫生部医政司.关于开展临床药师制试点工作的通知,2007.
  • 2希恩C斯威曼主编.李大魁,金有豫,汤光,等译.马丁代尔药物大典(原著第35版).化学工业出版社,2009:1017.
  • 3Gersh BJ.Chronic Coronary Artery Disease.In:Braunwald E,ed.Heart Disease:A Textbook of Cardiovascular Medicine,6th Ed.Philadelphia:WB Saunders,2001.
  • 4Juurlink DN,Gomes T,Ko DT,et al.A population-based study of the drug interaction between proton pump inhibitors and clopidogrel.CMAJ,2009,180(7):713-718.

共引文献3178

同被引文献36

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部